A preclinical study in mice reported that tumor-associated VEGF enhanced expression of PD-1 and other inhibitory checkpoints involved in CD8+ T cell exhaustion, such as CTLA-4, TIM-3, and LAG-3, and targeting VEGF reverted expression of inhibitory checkpoints (51). Here, CD8A is linked to neoplasm.